FDA.reportPublic FDA data

avacincapted pegol 2 MG in 0.1 ML Injection

RxCUI
2645112
RxNorm name
avacincapted pegol 2 MG in 0.1 ML Injection
Display name
avacincapted pegol 2 MG in 0.1 ML Injection
Full name
avacincapted pegol 2 MG in 0.1 ML Injection
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:38:48

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
1642fe6a-dc26-4d20-ae6e-654af744e3bdavacincapted pegol 2 MG in 0.1 ML Injection [PSN] · 0.1 ML avacincaptad pegol 20 MG/ML Injection [SCD] · avacincapted pegol 2 MG per 0.1 ML Injection [SY]39These highlights do not include all the information needed to use IZERVAY safely and effectively. See full prescribing information for IZERVAY. IZERVAY ® (avacincaptad pegol intravitreal solution) Initial U.S. Approval: 202320260227